Bitcoin (btc)$82,690.00↑ 1.29%
Ethereum (eth)$2,445.71↑ 2.08%
Tether (usdt)$0.999184↓ 0.00%
BNB (bnb)$739.48↑ 1.53%
XRP (xrp)$1.33↑ 2.37%
USDC (usdc)$0.999733↓ 0.02%
Solana (sol)$106.06↑ 1.24%
TRON (trx)$0.330752↓ 0.19%
Figure Heloc (figr_heloc)$1.025↑ 0.34%
Zcash (zec)$1,263.33↑ 10.56%
Hyperliquid (hype)$81.46↑ 3.02%
Dogecoin (doge)$0.081547↑ 2.72%
Monero (xmr)$576.62↓ 3.85%
USDS (usds)$1.001↑ 0.07%
WhiteBIT Coin (wbt)$80.87↑ 1.37%
Bitcoin (btc)$82,690.00↑ 1.29%
Ethereum (eth)$2,445.71↑ 2.08%
Tether (usdt)$0.999184↓ 0.00%
BNB (bnb)$739.48↑ 1.53%
XRP (xrp)$1.33↑ 2.37%
USDC (usdc)$0.999733↓ 0.02%
Solana (sol)$106.06↑ 1.24%
TRON (trx)$0.330752↓ 0.19%
Figure Heloc (figr_heloc)$1.025↑ 0.34%
Zcash (zec)$1,263.33↑ 10.56%
Hyperliquid (hype)$81.46↑ 3.02%
Dogecoin (doge)$0.081547↑ 2.72%
Monero (xmr)$576.62↓ 3.85%
USDS (usds)$1.001↑ 0.07%
WhiteBIT Coin (wbt)$80.87↑ 1.37%

Verge Genomics and Ferrer Collaborate to Advance ALS Drug Candidate VRG50635 Globally – Draper Decentralized – 9.19.24

Published September 19, 2024

Verge Genomics and Ferrer have partnered to co-develop VRG50635, a promising AI-discovered drug for ALS treatment. Ferrer will develop and commercialize the drug in select global markets, while Verge retains U.S. rights as it advances through clinical trials.